- A groundbreaking study, spearheaded by the University of Edinburgh, has identified a unique hormonal signature in individuals with endometriosis.
- Researchers observed distinct variations in androgens, often referred to as 'male' hormones, including high levels of 11-ketotestosterone, among those affected by the condition.
- This significant finding could lead to a simple, non-invasive diagnostic blood test, potentially reducing the current average nine-year diagnosis time for endometriosis in the UK.
- The study successfully identified over 95 per cent of endometriosis patients in the trial, challenging the traditional view of the condition as solely oestrogen-driven.
- The team is seeking industry partners to develop the diagnostic test and explore new therapeutic targets based on these insights, which could revolutionise treatment.
IN FULL
